Neck masses differential diagnosis: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Ssharfaei (talk | contribs)
editnews, nocaptcha, Administrators, Widget editors
7,502 edits
Ssharfaei (talk | contribs)
editnews, nocaptcha, Administrators, Widget editors
7,502 edits
Line 9: Line 9:
{|
{|
! rowspan="3" |Category
! rowspan="3" |Category
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! colspan="2" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
!
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
Line 19: Line 18:
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
|-
|-
!
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
Line 28: Line 26:
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
|-
|-
!
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
Line 37: Line 34:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Others
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Others
|-
|-
!Congenital
! rowspan="10" |Congenital
! align="center" style="background:#DCDCDC;" |'''Branchial cleft cyst'''  
! colspan="2" align="center" style="background:#DCDCDC;" |'''Branchial cleft cyst'''  
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 58: Line 54:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! colspan="2" align="center" style="background:#DCDCDC;" |'''Thyroglossal duct cyst'''
! align="center" style="background:#DCDCDC;" |'''Thyroglossal duct cyst'''
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 79: Line 73:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! colspan="2" align="center" style="background:#DCDCDC;" |'''Hemangioma'''
! align="center" style="background:#DCDCDC;" |'''Hemangioma'''
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 100: Line 92:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! colspan="2" align="center" style="background:#DCDCDC;" |Vascular malformations
! align="center" style="background:#DCDCDC;" |Vascular malformations
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 121: Line 111:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! colspan="2" align="center" style="background:#DCDCDC;" |Lymphatic malformations
! align="center" style="background:#DCDCDC;" |Lymphatic malformations
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 142: Line 130:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! colspan="2" align="center" style="background:#DCDCDC;" |'''Laryngocele'''  
! align="center" style="background:#DCDCDC;" |'''Laryngocele'''  
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 163: Line 149:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! colspan="2" align="center" style="background:#DCDCDC;" |'''Ranula'''  
! align="center" style="background:#DCDCDC;" |'''Ranula'''  
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 184: Line 168:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! colspan="2" |'''Teratoma'''  
!'''Teratoma'''  
!
!
!
!
!
Line 205: Line 187:
!
!
|-
|-
!
! colspan="2" |'''Dermoid cyst'''
!'''Dermoid cyst'''
!
!
!
!
!
Line 226: Line 206:
!
!
|-
|-
!
! colspan="2" |'''Thymic cyst'''  
!'''Thymic cyst'''  
!
!
!
!
!
Line 248: Line 226:
|-
|-
!Category
!Category
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
!
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
Line 268: Line 245:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
|-
|-
!Inflammatory
! rowspan="12" |Inflammatory
! align="center" style="background:#DCDCDC;" |'''Reactive viral lymphadenopathy'''
! colspan="2" align="center" style="background:#DCDCDC;" |'''Reactive viral lymphadenopathy'''
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 289: Line 265:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! colspan="2" |HIV
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
! align="center" style="background:#DCDCDC;" |'''Bacterial lymphadenopathy'''
!
!
|-
! rowspan="5" align="center" style="background:#DCDCDC;" |'''Bacterial lymphadenopathy'''
!Tularemia
!Tularemia
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 310: Line 304:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! align="center" style="background:#DCDCDC;" |
!Brucellosis
!Brucellosis
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 331: Line 323:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! align="center" style="background:#DCDCDC;" |
!Cat-scratch disease
!Cat-scratch disease
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 352: Line 342:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! align="center" style="background:#DCDCDC;" |
!Actinomycosis  
!Actinomycosis  
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 373: Line 361:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! align="center" style="background:#DCDCDC;" |
!Mycobacterial infections  
!Mycobacterial infections  
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 394: Line 380:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! align="center" style="background:#DCDCDC;" |
!HIV
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
|-
!
! align="center" style="background:#DCDCDC;" |'''Parasitic lymphadenopathy'''
! align="center" style="background:#DCDCDC;" |'''Parasitic lymphadenopathy'''
!Toxoplasma gondii
!Toxoplasma gondii
Line 436: Line 400:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! colspan="2" align="center" style="background:#DCDCDC;" |Sarcoidosis
! align="center" style="background:#DCDCDC;" |Sarcoidosis
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 457: Line 419:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! colspan="2" align="center" style="background:#DCDCDC;" |Castleman disease
! align="center" style="background:#DCDCDC;" |Castleman disease
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 478: Line 438:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! colspan="2" align="center" style="background:#DCDCDC;" |Rosai-Dorfman disease
! align="center" style="background:#DCDCDC;" |Rosai-Dorfman disease
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 499: Line 457:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! colspan="2" |Kawasaki disease
!Kawasaki disease
!
!
!
!
!
Line 521: Line 477:
|-
|-
!Category
!Category
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
!
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
Line 541: Line 496:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
|-
|-
!Neoplasm
! rowspan="16" |Neoplasm
! align="center" style="background:#DCDCDC;" |'''primary thyroid tumor'''
! colspan="2" align="center" style="background:#DCDCDC;" |'''primary thyroid tumor'''
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 562: Line 516:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! rowspan="10" align="center" style="background:#DCDCDC;" |'''Salivary gland neoplasm'''
! align="center" style="background:#DCDCDC;" |'''Benign salivary gland neoplasm'''
!pleomorphic adenoma
!pleomorphic adenoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 583: Line 536:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! align="center" style="background:#DCDCDC;" |
!Warthin's tumor
!Warthin's tumor
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 604: Line 555:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
! align="center" style="background:#DCDCDC;" |
!lymphoepithelioma
!lymphoepithelioma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 625: Line 574:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
!
!
!oncocytoma
!oncocytoma
!
!
!
!+
!
!
!
!
Line 646: Line 593:
!
!
|-
|-
!
!
!monomorphic adenoma
!monomorphic adenoma
!
!
!
!+
!
!
!
!
Line 667: Line 612:
!
!
|-
|-
!
!'''Malignant salivary gland neoplasm'''
!mucoepidermoid carcinoma
!mucoepidermoid carcinoma
!
!
!
!
!
!+
!
!
!
!
Line 688: Line 631:
!
!
|-
|-
!
!
!adenoid cystic carcinoma
!adenoid cystic carcinoma
!
!
!
!
!
!+
!
!
!
!
Line 709: Line 650:
!
!
|-
|-
!
!
!adenocarcinoma
!adenocarcinoma
!
!
!
!
!
!+
!
!
!
!
Line 730: Line 669:
!
!
|-
|-
!
!
!salivary duct carcinoma
!salivary duct carcinoma
!
!
!
!
!
!+
!
!
!
!
Line 751: Line 688:
!
!
|-
|-
!
!
!squamous cell carcinoma
!squamous cell carcinoma
!
!
!
!
!
!+
!
!
!
!
Line 772: Line 707:
!
!
|-
|-
!
! colspan="2" |'''Paraganglioma'''
!'''Paraganglioma'''
!
!
!
!
!
Line 793: Line 726:
!
!
|-
|-
!
! colspan="2" |'''Schwannoma'''  
!'''Schwannoma'''  
!
!
!
!
!
Line 814: Line 745:
!
!
|-
|-
!
! colspan="2" |'''Lymphoma'''  
!'''Lymphoma'''  
!
!
!
!
!
Line 835: Line 764:
!
!
|-
|-
!
! colspan="2" |'''Lipoma'''  
!'''Lipoma'''  
!
!
!
!
!
Line 856: Line 783:
!
!
|-
|-
!
! colspan="2" align="center" style="background:#DCDCDC;" |'''Metastatic head and neck carcinoma'''
! align="center" style="background:#DCDCDC;" |'''Metastatic head and neck carcinoma'''
!
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 878: Line 803:
|-
|-
!Category
!Category
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
!
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign

Revision as of 17:34, 14 January 2019

Neck masses Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neck Masses from other Conditions

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neck masses differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Neck masses differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neck masses differential diagnosis

CDC on Neck masses differential diagnosis

Neck masses differential diagnosis in the news

Blogs on Neck masses differential diagnosis

Directions to Hospitals Treating Neck masses

Risk calculators and risk factors for Neck masses differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Differentiating neck masses from other Diseases

Differential diagnosis of neck masses include:

Category Diseases Etiology Benign Malignant Clinical manifestation Paraclinical findings Gold standard diagnosis Associated findings
Demography History Symptoms Signs Lab findings Histopathology Imaging
Mass Pain Dysphagia Mass exam Skin changes LAP Others
Congenital Branchial cleft cyst
Thyroglossal duct cyst
Hemangioma
Vascular malformations
Lymphatic malformations
Laryngocele
Ranula
Teratoma
Dermoid cyst
Thymic cyst
Category Diseases Etiology Benign Malignant Demography History Mass Pain Dysphagia Mass exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings
Inflammatory Reactive viral lymphadenopathy
HIV
Bacterial lymphadenopathy Tularemia
Brucellosis
Cat-scratch disease
Actinomycosis
Mycobacterial infections
Parasitic lymphadenopathy Toxoplasma gondii
Sarcoidosis
Castleman disease
Rosai-Dorfman disease
Kawasaki disease
Category Diseases Etiology Benign Malignant Demography History Mass Pain Dysphagia Mass exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings
Neoplasm primary thyroid tumor
Salivary gland neoplasm pleomorphic adenoma +
Warthin's tumor +
lymphoepithelioma +
oncocytoma +
monomorphic adenoma +
mucoepidermoid carcinoma +
adenoid cystic carcinoma +
adenocarcinoma +
salivary duct carcinoma +
squamous cell carcinoma +
Paraganglioma
Schwannoma
Lymphoma
Lipoma
Metastatic head and neck carcinoma
Category Diseases Etiology Benign Malignant Demography History Mass Pain Dysphagia Mass exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings

References

Retrieved from "https://www.wikidoc.org/index.php?title=Neck_masses_differential_diagnosis&oldid=1535561"